Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27863523)

Published in J Hematol Oncol on November 18, 2016

Authors

Zhenyi Jin1, Qiang Luo1, Shuai Lu2, Xinyu Wang1, Zifan He1, Jing Lai1,3, Shaohua Chen1, Lijian Yang1, Xiuli Wu4, Yangqiu Li5,6,7

Author Affiliations

1: Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China.
2: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China.
3: Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China.
4: Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China. siulier@163.com.
5: Institute of Hematology, Medical College, Jinan University, Guangzhou, 510632, China. yangqiuli@hotmail.com.
6: Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, 510632, China. yangqiuli@hotmail.com.
7: Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, 510632, China. yangqiuli@hotmail.com.

Articles cited by this

Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol (2013) 3.77

Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med (1989) 3.70

Acute Myeloid Leukemia. N Engl J Med (2015) 2.85

Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol (1994) 2.21

Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer. J Immunol (2012) 1.38

V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells. J Immunol (2010) 1.20

Diversity of γδ T-cell antigens. Cell Mol Immunol (2012) 1.19

Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia (2005) 1.10

Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+ leukemia model. PLoS One (2011) 1.02

Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. Br J Haematol (2012) 1.00

Characterization of the gammadelta T cell response to acute leukemia. Cancer Immunol Immunother (2005) 0.99

In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma. Br J Haematol (2007) 0.97

Homoharringtonine and omacetaxine for myeloid hematological malignancies. J Hematol Oncol (2014) 0.93

TRAV and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T-cells. Transpl Immunol (2007) 0.93

Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes. Haematologica (2008) 0.91

Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease. J Transl Med (2011) 0.91

Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia. Neoplasma (2002) 0.91

The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation. Mol Cancer (2013) 0.91

TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood. Transpl Immunol (2008) 0.87

Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations. J Hematol Oncol (2014) 0.87

Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients. Hematology (2011) 0.86

The roles of stem cell memory T cells in hematological malignancies. J Hematol Oncol (2015) 0.85

Plasticity of γδ T Cells: Impact on the Anti-Tumor Response. Front Immunol (2014) 0.83

Gamma delta T-cell differentiation and effector function programming, TCR signal strength, when and how much? Cell Immunol (2015) 0.81

Comparison of the distribution and clonal expansion features of the T-cell γδ repertoire in myelodysplastic syndrome-RAEB and RAEB with progression to AML. DNA Cell Biol (2012) 0.81

The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura. Hematology (2009) 0.81

Distribution and clonality of the vα and vβ T-cell receptor repertoire of regulatory T cells in leukemia patients with and without graft versus host disease. DNA Cell Biol (2014) 0.80

The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma. J Immunol Res (2014) 0.80

The T-cell receptor Vbeta gene repertoire and clonal expansion from peripheral blood T cells in benzene-exposed workers in China. Hematology (2009) 0.79

Upregulated TCRζ improves cytokine secretion in T cells from patients with AML. J Hematol Oncol (2015) 0.78

Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy. J Hematol Oncol (2015) 0.77

Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer. Int J Cancer (2016) 0.77

Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI. Oncotarget (2016) 0.77